Terpinen-4-ol, sometimes misspelled in trade datasets as terpinene-4-ol, is the signature monoterpene alcohol of tea tree oil and a recurring secondary constituent in lavender, marjoram, plai, petitgrain, and several conifer-adjacent oils in the AromaForge archive. The evidence base is relatively strong for identity, tea-tree chemotype relevance, antimicrobial screening, and inflammatory mediator modulation in preclinical systems. The benefit-facing literature is still mostly in vitro or animal work rather than human clinical proof, so this record should stay chemistry-first and avoid medical claims.
Chemical identity and composition
PubChem identifies terpinen-4-ol as CID 11230 with formula C10H18O. The core tea tree pharmacology literature consistently uses the spelling terpinen-4-ol, while this archive assignment uses the variant id terpinene_4_ol; the record therefore preserves the assigned id but grounds identity in the terpinen-4-ol registry trail. In local oil data, terpinen-4-ol ranges from a chemotype-defining dominant constituent in tea tree and plai to a smaller supporting marker in lavender, mastic leaf, nutmeg, and other aromatic profiles.
Aroma and practical use
- Use the recorded fresh, herbal, tea tree-like, camphoraceous, woody descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2000 Inflammation Research study reported that terpinen-4-ol, but not the other tested water-soluble tea tree constituents, suppressed LPS-induced TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 production in activated human monocytes.
A 2000 Inflammation Research study reported that terpinen-4-ol, but not the other tested water-soluble tea tree constituents, suppressed LPS-induced TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 production in activated human monocytes.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2008 Letters in Applied Microbiology study reported that terpinen-4-ol showed greater bacteriostatic and bactericidal activity than tea tree oil against tested MRSA and coagulase-negative staphylococcal skin isolates, while neither agent was toxic to human fibroblasts over 24 hours at the tested concentrations.
A 2008 Letters in Applied Microbiology study reported that terpinen-4-ol showed greater bacteriostatic and bactericidal activity than tea tree oil against tested MRSA and coagulase-negative staphylococcal skin isolates, while neither agent was toxic to human fibroblasts over 24 hours at the tested concentrations.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2013 oral candidiasis paper reported that terpinen-4-ol suppressed inflammatory reactions in a murine model and reduced the inflammatory severity associated with Candida albicans infection.
A 2013 oral candidiasis paper reported that terpinen-4-ol suppressed inflammatory reactions in a murine model and reduced the inflammatory severity associated with Candida albicans infection.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot assessed
Not assessed in the available record.
Penetration enhancementNot assessed
Not assessed in the available record.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA 2016 contact-allergy review described fresh tea tree oil as a weak to moderate sensitizer and noted that oxidation increases allergenic potency; this is relevant context for terpinen-4-ol-rich materials even though the review is oil-level rather than an isolated-compound dermal threshold study.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The 2008 skin-isolate study reported no fibroblast toxicity over 24 hours at the tested concentrations, but that should not be treated as a general human safety clearance.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
A constituent-specific modern human dermal limit or inhalation threshold for isolated terpinen-4-ol was not verified in this research pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
TerpinoleneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Terpinolene report →alpha-TerpineolOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read 1,8-cineole report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read alpha-Terpineol report →p-CymeneOpposing candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read p-Cymene report →LinaloolNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →MyrceneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Myrcene report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →Decanoic acidAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
mixed · effect
No source citation attached.
Read Decanoic acid report →How the effects were investigated
suppressed_cytokine_and_pge2_output
In LPS-activated human monocytes, terpinen-4-ol suppressed TNF-alpha, IL-1beta, IL-8, IL-10, and PGE2 production, which is the clearest direct mechanism signal located in accessible primary literature.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
reduced_inflammatory_response_in_infection_model
A murine oral candidiasis study reported lower tongue inflammatory parameters after terpinen-4-ol treatment, supporting a preclinical inflammation-modulating effect in vivo.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Most terpinen-4-ol efficacy evidence remains in vitro or animal-model work rather than human clinical studies.
- Many safety discussions are inferred from tea tree oil mixture literature instead of isolated-compound exposure studies.
- The assigned id uses the variant spelling terpinene_4_ol, but the source literature and registry trail are centered on terpinen-4-ol.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.